Postpartum pharmacokinetics of peramivir in the treatment of 2009 H1N1 influenza.

Background 2009 H1N1 influenza A disproportionately affected pregnant and postpartum women compared to the general population with higher rates of hospitalization and severe illness. The purpose of this study was to examine the use and pharmacokinetics of intravenous peramivir in the treatment of a newly postpartum patient with severe influenza.